NCT00004244View on ClinicalTrials.gov

Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

July 31, 2005

Study Completion Date

September 30, 2008

Conditions
Kidney CancerMelanoma (Skin)
Interventions
BIOLOGICAL

recombinant interferon alfa

BIOLOGICAL

recombinant interleukin-12

Trial Locations (1)

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

All Listed Sponsors
collaborator

The Cleveland Clinic

OTHER

lead

National Cancer Institute (NCI)

NIH

NCT00004244 - Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma | Biotech Hunter | Biotech Hunter